Amneal Pharmaceuticals
(NASDAQ:AMRX)
$6.66
0.19[2.94%]
At close: May 10
$6.66
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Amneal Pharmaceuticals Stock (NASDAQ:AMRX), Quotes and News Summary

Amneal Pharmaceuticals Stock (NASDAQ: AMRX) stock price, news, charts, stock research, profile.

Open$6.500
Close$6.660
Volume / Avg.1.142M / 1.641M
Day Range6.490 - 6.750
52 Wk Range1.740 - 6.900
Market Cap$2.055B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
65
Short Interest
1.09%
Days to Cover1.79

Recent News

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement
Amneal Pharmaceuticals settles $270 million opioid crisis agreement, offering cash and naloxone spray. Boosted by strong Q1 earnings, the company reaffirms fiscal guidance.
Vandana Singh
Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?
Amneal Pharmaceuticals reveals Q4 2023 results with $616.98 million revenue, up 1% YoY. Despite an 8% drop in adjusted EBITDA, the company beats EPS expectations. Co-CEOs anticipate growth in 2024, projecting revenues of $2.55-$2.65 billion and adjusted EPS of $0.53-$0.63.
Vandana Singh
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
2
Mar
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AMRX
SUPN

FAQ

Q

How do I buy Amneal Pharmaceuticals (AMRX) stock?

A

You can purchase shares of Amneal Pharmaceuticals (NASDAQ: AMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Amneal Pharmaceuticals's (AMRX) competitors?

A

Other companies in Amneal Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Neumora Therapeutics (NASDAQ:NMRA).

Q

What is the target price for Amneal Pharmaceuticals (AMRX) stock?

A

The latest price target for Amneal Pharmaceuticals (NASDAQ: AMRX) was reported by Goldman Sachs on Monday, May 6, 2024. The analyst firm set a price target for 8.00 expecting AMRX to rise to within 12 months (a possible 20.12% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Amneal Pharmaceuticals (AMRX)?

A

The stock price for Amneal Pharmaceuticals (NASDAQ: AMRX) is $6.66 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Amneal Pharmaceuticals (AMRX) pay a dividend?

A

There are no upcoming dividends for Amneal Pharmaceuticals.

Q

When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?

A

Amneal Pharmaceuticals’s Q2 earnings are confirmed for Friday, August 2, 2024.

Q

Is Amneal Pharmaceuticals (AMRX) going to split?

A

There is no upcoming split for Amneal Pharmaceuticals.

Q

What sector and industry does Amneal Pharmaceuticals (AMRX) operate in?

A

Amneal Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch